Zusammenfassung
Die klinische und ätiologische Poliomyelitisforschung hat uns mit 2 Tatsachen bekannt gemacht, die bei der folgenden Betrachtung in erster Linie im Auge behalten werden müssen.
Aus der Universitäs- Kinderklinik Freiburg i. Br. Direktor Prof. Dr. W. Keller
Abgeschlossen am 1.8. 1953
Chapter PDF
Similar content being viewed by others
Literatur
Ainslie, J. D.: Increase in virulence of the Lansing strahl of poliomyelitis virus with passage in mice. J. of Immun. 67, 331 (1951).
Andrewes, C. H.: Viruses and Linnaeus. Acta path. scand. (Copenh.) 28, 211 (1951).
Armstrong, C. H.: Successful transfer of Lansing strain of poliomyelitis virus from the cotton rat to the white mouse. Publ. Health Rep. 54, 2302 (1939).
Behrend, R. Ch.: Die sogenannten Poliomyelitiden. Eine Übersicht über die Erforschung der Heine-Mediürschen Krankheit in den Jahren 1940 1952. Fortschr. Neur. 20, 493 (1952)
Bodian, D.: The virus, the nerve cell and paralysis. Study of experimental poliomyelitis in the spinal cord. Bull. Hopkins Hosp. 83, 1 (1948).
—.:Poliomyelitis. Pathological anatomy. Papers and discussions. Internat. Poliomvelitis Conf. 1, 62 (1949).
—:A reconsideration of the pathogenesis of poliomyelitis. Amer. J. Hyg. 55, 414 (1952).
—and M. C. Cumberland: The rise and decline of poliomyelitis virus levels in infected nervous tissue. Amer. J. Hyg. 45, 226 (1947).
— and H. A. Howe: Nonparalytic poliomyelitis in chimpanzee and in human poliomyelitis. J. of Exper. Med. 81, 255 (1945).
—:Experimental studies on intraneural spread of poliomyelitis virus. Bull. Hopkins Hosp. 68, 248 (1941).
Bürnet, M. F.: Virus Classification and nomenclature. Ann. N. Y. Acad. Sci. 56, 383 (1953).
Committee on typing of the National Foundation for infantile paralysis: Amer. J. Hvg. 54, 191 (1951).
Enders, J. F.: Vermehrung und Eigenschaften der Poliomyelitis-Viren auf menschlichen Gewebskulturen. 2. Internat. Poliomyelitis-Konf. Kopenhagen 1951.
Hallauer, C.: Die Hämagglutination durch murine Poliomyelitisstämme. Arch. Virusforsch. (Wien) 4, 224 (1951).
Holmes, F. O.: The filtrable viruses. Bergeys manualof determinative Bacteriology, Edit. VI. Baltimore: Wilhams and Wilkins Comp. 1948.
Horstmann, D. M.: Poliomyelitis virus in blood of orally infected monkeys and Chim-panzees. Proc. Soc. Exper. Biol. a. Med. 79, 417 (1952).
Jungeblut, C. W.: A preliminary note on the isolation of human poliomyelitis virus from the heart of fatal cases of the disease. 3. Europ. Internat. Poliomyelitis-Konf. Amsterdam 1950.
—:Problems of Classification of poliomyelitis virus. Arch. of Path. 52, 18 (1951).
Jungeblut, C. W. and Edwards, J. E.: Isolation of poliomyelitis virus from the heart in fatal cases. Amer. J. Clin. Path. 21, 601 (1951).
— Stevens: Attempts to isolate poliomyelitis virus from the paralyzed muscle of patients during the acute stage of the disease. Amer. J. Clin. Path. 20, 701 (1950).
Kalm, H.: Zur Topik des anatomischen Prozesses bei der Heine-MEDiNschen Krankheit. Dtsch. Z. Nervenheilk. 164, 92 (1950).
—: Zum Verständnis des Lähmungsverlaufs bei der Heine-MEDiNschen Krankheit. Dtsch. Z. Nervenheilk. 167, 187 (1952).
Koch, R.: Über bakteriologische Forschung. Verh. io. Internat. Med. Kongreß Berlin 1, 35 (1890).
Koprowski, H.: Discussion of Classification and nomenclature of the poliomyelitis virus group. Ann. N. Y. Acad. Sci. 56, 596 (1953).
T. W. Norton and W. Mc Dermott: Isolation of poliomyelitis virus from human serum by direct inoculation into a laboratory mouse. Publ. Health Rep. 62, 1467 (1947).
Li, C. P., and K. Habel: Adaption of Leon strain of poliomyelitis to mice. Proc. Soc. Exper. Biol. a. Med. 78, 233 (1951).
—Habel and M. Schaeffer: Adaption of type I poliomyelitis virus to mice. Proc. Soc. Exper. Biol. a. Med. 82, 477 (1953).
Mollaret, P.: Le demembrement de la poliomyelite, sa necessite et ses criteres de Classification. Presse med. 58, 1096 (1950).
—:Le demembrement de la poliomyelite. II. Les maladies poliomyelitiques humaines fondamentales. Presse med. 58, 1205 (1950).
—:Le demembrement de la poliomyelite. III. Les maladies poliomyelitiques frontieres. Presse med. 58, 1223 (1950).
—:Le demembrement de la poliomyelite IV. Maladies pseudopoliomyelitiques veterinaires, synthese et perspectives. Presse med. 58, 1255 (1950).
Paul, J. R.: Knowledge and trends in poliomyelitis. A summary. 2. Internat. Poliomyelitis Conf. Copenhagen 1951.
Pette, H.: Die akut entzündlichen Erkrankungen des Nervensystems. Leipzig: Georg Thieme 1942.
—: Wandlungen epidemiologischer und pathogenetischer Gedankengänge bei der Poliomyelitis. Klin. Wschr. 1949, 321.
Rhodes, J. A.: Classification and nomenclature of the poliomyelitis group of viruses. Ann. N. Y. Acad. Sci. 56, 604 (1953).
Sabin, A. B.: Epidemiologie patterns of poliomyelitis in different parts of the world and in different population groups. Papers a. Diseussions Internat. Poliomyelitis Conf. 1, 3 (1949).
—:Diskussion 2. Internat. Poliomyelitis-Konf. Kopenhagen 1951.
—: Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups. Amer. J. Publ. Health 41, 1215 (1951).
Salk, J. E.: Immunologie Classification of poliomyelitis viruses. 2. Internat. Poliomyelitis Konf. Kopenhagen 1951.
Verlinde, J. D., P. de Baan and J. A. Vercruysse: The monkey pathogenicity of the Col SK virus and the mouse adapted Lansing strain of poliomyelitis virus and the influence of monkey passage on the characteristics of the virus. Leeuwenhoek J. Microbiol. a. Serol. 16, 9 (1950).
— and B. Beem: Haematogenous spread of poliomyelitis virus. Leeuwenhoek J. Microbiol. a. Serol. 18, 1 (1952).
Wenner, H. A., and F. E. Rabe: The recovery from regional lymphnodes of fatal human cases of poliomyelitis. Amer. J. Med. Sci. 222, 292 (1951).
Parapoliomyelitis
Anderson, J. A., and V. Bolin: Zit. nach Knox. Endocrinology (Springfield, III.) 89, 67 (1946).
—: Congenital antiviral immunity in Swiss mice. Amer. J. Hyg. 50, 200 (1950).
de Baan, P.: Hemagglutie door neurotrope virussorten. Proefschrift, Leiden 1950.
Anderson, J. A., and V. Bolin: Verh. Inst. Praev. Geneesk. Leiden 1950, 17.
J. D. Verlinde and P. Waller-Fetter: Studies on hemagglutination by the EMC-MM- Col. SK group of viruses. I. Factors influencing the hemagglutination reaction. Leeuwenhoek J. Microbiol. a. Serol. 17, 119 (1951).
Beller, K., u. W. Keller: Zur Ätiologie akut entzündlicher Erkrankungen des Zentralnervensystems, im besonderen der Poliomyelitis. Klin. Wschr. 1949, 422.
Betke, K., u. R. Gädeke: Zvtologische und histologische Untersuchungen über retikuläre Gewebsreaktionen bei experimenteller Infektion mit Viren der EMC-Gruppe. 3. Kongreß Internat. Europ. Ges. Hämatologie, Rom 1951.
—: Das klinische Syndrom „Enzephalomyokarditis”. Arch. Kinderheilk. 146, 6 (1953).
—: Epidemische Häufung von Erkrankungen mit enzephalitischem Symptomenbild in Südbaden 1951. Mschr. Kinderheilk. 100, 392 (1952).
—: Bibliographie of infantile paralysis 1789–1949. Nat. Found. Inf. Paral. 1951.
Bieling, R.: Weitere Untersuchungen über virusbedingte Enzephalomyelitis des Menschen. Österr. Mikrobiologen-Tagung, Salzburg 1950.
—: Viruserkrankungen des Nervensystems. 1. Die Biologie der Viruskrankheiten. Dtsch. Z. Nervenheilk. 167, 516 (1952).
—: Systematische und ätiologische Untersuchungen auf dem Virusgebiet. Wien. klin. Wschr. 1952, 481.
— Koch: Virusbedingte Enzephalomyelitiden. Marburg, med. Ges. v. 14. 12. 1949.
—: Versuch einer Differentialdiagnose der abakteriellen Meningitis. Z. Kinderheilk. 72,. 85 (1952).
Bingel, K. F., u. H. Engelhardt: Möglichkeiten und Aussichten einer Expositionsprophylaxe bei der Poliomyelitis. Kim. Wschr. 1953, 683.
Blattner, R. J.: Encephalomyoearditis. J. of Pediatr. 42, 267 (1953).
Boxjrdillon, J.: Purification, Sedimentation and serological reactions of the murine strain of SK-poliomyelitis virus. Arch. of Biochem. 8, 285 (1944).
— and D. H. Moore: Attempts at purification of a murine strain of human poliomyelitis virus. Science (Lancaster, Pa.) 96, 541 (1942).
Bremer, A.: Recherehes sur l’agglutination des hematies par les souches murines de virus poliomyelitique. Ann. Inst. Pasteur 80, 40 (1951).
— et W. Mutsaars: Agglutination des globules rouges de mouton par le virus de la poliomyelite, (souche Lansing). C. r. Soc. Biol. (Paris) 142, 1194 (1948).
Brutsaert, P., C. W. Jungeblut and A. Knox: Attempts to propagatemurine poliomyelitis virus on various intestinal bacteria and protozoa. Proc. Soc. Exper. Biol. a. Med. 61, 265 (1946).
—, C. W. Jungeblut and A. Knox: Attempts to adapt murine poliomyelitis virus to the chick. J. of Pediatr. 29, 350 (1946).
Burrows, M. T.: Is poliomyelitis a disease of the lymphatic system? Arch. Int. Med. 48, 33 (1931).
Casals, J., and L. V. Brown: Haemagglutination with Gertain arthropod borne viruses. Proc. Soc. Exper. Biol. a. Med. 88, 170 (1953).
Chanok, R. M., and A. B. Sabin: Hemagglutinins of the St. Louis and western equine encephalitis viruses. Isolation, properties and use for diagnosis and epidemic survey. Amer. J. Dis. Childr. 84, 628 (1952).
Chiart, H.: Zur Kenntnis der Enzephalomyokarditis. Wien. klin. Wschr. 1952, 653.
—: Collomb et Merlihot: Origine virale probable d’une pericardite aecompagnee d’une encephalite et d’une pneumopathie aigue. Reunions medico-chirurgales de Saigon-Cholon. v. 27. 6. 1952.
Curley, F. J., and J. E. Gordon: Immunization of young mice with unmodified MM mouse encephalomyelitis virus under passive protection from immune mothers. Amer. J. Hyg. 48, 81 (1948).
Dalldorf, G.: Method of ultraviolet irradiation of virus to produce a Vaccine. Ann. Rep. Div. Labor. Res. Albany, 1948.
—: The etiology of poliomyelitis. N. Y. State J. Med. 49, 2053 (1949).
—: Report of the director. Ann. Rep. Div. Lab. Res., Albany 1951.
— and Withney, E.: Immunologie relationship of MM, Lansing poliomyelitis and mouse encephalomyelitis viruses. Proc. Soc. Exper. Biol. a. Med. 59, 150 (1945).
Dean, D. J.: The response of certain domesticated animals to injeetions of Coxsackie, MM and Theiler viruses. Ann. Rep. Div. Labor. Res., Albany 1951, 10.
Deibel, F.: Das Verhalten der heterophilen Hammelblutagglutinine in menschlichen Seren bei entzündlichen abakteriellen Erkrankungen des Zentralnervensystems. Z. Kinderheilk. 72, 476 (1953).
Dick, G. W. A.: Mengo-encephalomyelitis virus. Pathogenicity for animals and physical properties. Brit. J. Exper. Path. 29, 559 (1948).
—: The relationship of Mengo-encephaütis, Encephalomyocarditis, Columbia SK and MM- viruses. J. of Immun. 62, 375 (1949).
—: Cultivation of Mengo-encephalomyelitis virus in the embryonated hen egg. Proc. Soc. Exper. Biol. a. Med. 73, 77 (1950).
A. M. Best, A. J. Haddow and K. C. Smithburn: Mengo-enceplialitis, a hitherto unknown virus affecting man. Lancet 255, 286 (1948).
K. C. Smithburn and A. J. Haddow: Mengo-encephalomyelitis virus. Isolation and immunologieal properties. Brit. J. Exper. Path. 29, 547 (1948).
Enright, J. B and E.W Schultz: Further observations on the cultivation of strains of poliomyelitis virus in developing eggs. Proc. Soc. Exper. Biol. a. Med. 66, 541 (1947).
Evans, C. A., and V.C. Chambers: Growth of neurotropic viruses in extraneural tissues. I. MM-virus in the feet of hamsters. Proc. Soc. Exper. Biol. a. Med. 68, 436 (1948).
—, and R. G. Green: Extraneural growth of poliomyelitis virus. Its significance relative to possible methods of prevention. J. Amer. Med. Assoc. 134, 1154 (1947).
Eyquem, M. A., G. Cateigne et M. G Hannoun: Influence des enzymes proteolytiqiies sur l’agglutinabilite des globules rouges par les virus. Soc. frang. Microbiol. v. 8. 5. 1952.
Fastier, L. B.: Studies on hemagglutination with the GD VII strain of murine encephalomyelitis. J. of Immun. 65, 323 (1950).
Fastier, L. B.: Factors involved in hemagglutination by the GD VII strain of murine encephalomyelitis virus. J. of Immun. 66, 365 (1951).
Findlay, G. M., and E. M. Howard: Virus exaltation. Brit. J. Exper. Path. 31, 45 (1950).
—: Observations on Col. SK virus. J. of Path. 63, 435 (1951).
Fishgold, J. T.: Reduced capacity of brain homogenates from mice infected with Col SK and ectromelia viruses to rednce triphenyltetrazolium chloride. Federat. Proc. 10, 294 (1951).
Francis, Th., and G. Brown: Evaluation of the effect of Darvisul upon infection with SK- strain of virus in mice. Proc. Soc. Exper. Biol. a. Med. 70, 535 (1949).
Gädeke, R.: Morphologische Grundlagen neuerer Anschauungen über das Krankheitsbild der Poliomyelitis. Virchows Arch. 822, 563 (1952).
Bayer, EL, B. Hammel, S. Kanzler u. F. Schönberg: Vergleichende experimentelle Untersuchungen über das Verhalten des Skeletmuskelgewebes der Albinomaus nach Infektion mit murinen mausadaptierten und klassischen Poliomyelitis-Viren. I. Mitteilung Untersuchungen mit dem MM-Virus. Arch. Virusforsch. (Wien). (Im Druck.)
—, B. Hammel, S. Kanzler, F. Schönberg u. K. Betke: Die Wirkung von Viren der Parapoliomyelitisgruppe auf die lymphatischen Organe der Maus. Z. Naturforsch. 7b, 401 (1952).
—, B. Hammel, S. Kanzler F. Schönberg u. S. Kanzler: Rhythmische Verteilung der Absterbehäufigkeit weißer Mäuse nach unterschiedlich modifizierter Infektion mit dem MM-Virus. Naturwissenschaften 40, 587 (1953).
Gajrd, S., and L. Heller: Hemagglutination by Col-MM Virus. Proc. Soc. Exper. Biol. a. Med. 76, 68 (1951).
— and O. Lindholm: Experiments on formalized poliomyelitis virus vaccines. Acta med. scand. (Stockh.) 120, 184 (1947).
— et Odier: Remarques sur Fagglutination des globules rouges de mouton par le virus de la poliomyelite, souche MM. Ann. Inst. Pasteur 79, 197 (1950).
Gerstner, A.: Untersuchungen mit dem Hämagglutinationshemmungstest auf Antikörper gegen Viren der Parapoliomyelitisgruppe in Seren von Patienten mit Erkrankungen des Zentralnervensystems sowie zur Frage der Spezifität dieses Testes. Diss. Freiburg 1953.
Goldfeder, A., L. Cohen, C. Miller and M. Singer: Electronmicroscopy of the purified MM poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 67, 366 (1948).
Gollan, F.: Purification of the MM poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med.364 (1948).
— and M. B. Visscher: Water, sodium and potassium content of normal and encephalo- myelitic mouse brain. Proc. Soc. Exper. Biol. a. Med. 76, 746 (1951).
Gordon, J. E., and F. J. Ctjrley: Induced latent infection and resultant immunity to MM mouse encephalitis virus in mice suckled by immune foster mothers. J. Inf. Dis. 85, 259 (1949).
Hallauer, C.: Proc. Internat. Kongress f. Mikrobiologie Kopenhagen 1947. S. 257.
Hallauer, C.: Über Hämagglutmation durch Virusarten. Bull. Schweiz. Akad. med. Wiss. 8, 81 (1947/48).
—: Die Hämagglutination durch Virusarten. (Phänomen von G. K. Hirst.) Handbuch d. Virusforsch. 2. Erg. Band S. 141 ff. Wien: Springer-Verlag 1950.
—: Die Hämagglutination muriner Poliomyelitisstämme. Arch. Virusforsch. (Wien) 4, 224 (1951).
Hammon, W. M., R. B. Aird and G. Sather: Failure of trypan red to protect against eertain neurotropic viruses (MM and Russian spring-summer encephalitis). Proc. Soc. Exper. Biol. a. Med. 60, 511 (1948).
Hellmann, T.: Studien über das lymphoide Gewebe. Beitr. path. Anat. 68, 333 (1921).
Helwig, F. C., and E. C. H. Schmidt: A filter passing agent produeing interstitial myocarditis in anthropoid apes and small animals. Science (Lancaster, Pa.) 102, 31 (1945).
Hettche, O., u. W. H. Schulz-Ehlbeck: Epidemiologie und Prophylaxe der Poliomyelitis im Hinblick auf die Rolle des Wassers bei der Übertragung. (Im Druck.)
Hofman, B.: Over een virusreceptorvernietigende eigenschap van speeksel en haar mogelijke betekenis voor de infectie met poliomyelitis virus. Proefschrift Leiden 1953.
Hofman, B. u. C. W. Jungeblut: Untersuchungen über Neutralisation und Hämagglutinationshemmung von Parapoliomyelitisvirus (Col. SK-Stamm) mit Seren von Fällen von Encephalitis, aseptischer Meningitis und Poliomyelitis. Ioin. Wschr. 80, 1013 (1952).
—: Further studies on Col. SK virus hemagglutination. Arch. Virusforsch. 5, 228 (1953).
—, B. and C. W. Jungeblut: Studies on hemagglutination by Col SK-Virus. J. of. Immun. 627 (1952).
Jawetz, E.: Hemagglutination by viruses. Its biological implications. Calif. Med. 69, 435 (1948).
Jungeblut, C. W.: Serological relationship within the poliomyelitis group of viruses. Amer. J. Publ. Health 84, 259 (1944).
—: Seasonal fluctuations in susceptibility of guinea pigs to experimental eavian poliomyelitis. Proc. Soc. Exper. Biol. a. Med. 58, 177 (1945).
—: Studies in rodent poliomyelitis. VI. Further observations on interference between murine and simian strains of poliomyelitis virus. J. of Exper. Med. 81, 275 (1945).
—.: Sensitization experiments in guinea pigs following injection with simian or rodent poliomyelitis virus. J. Allergy 18, 239 (1947).
—: Mechanism of infeetion in rodent poliomyelitis in relation to age and portal of entry. J. Inf. Dis. 81, 282 (1947).
—: Active and inactive murine poliomyelitis virus as interfering agents against poliomyelitis infeetion in monkeys. Proc. Soc. Exper. Biol. a. Med. 68, 19 (1948).
—: Reverse interference between simian and murine poliomyelitis virus in guinea pigs. Proc. Soc. Exper. Biol. a. Med. 68, 615 (1948).
—: Failure of phenolsulfazole to influence the course of infeetion with murine poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 70, 371 (1949).
—.: Monkey pathogenicity of various strains of murine poliomvelitis virus. II. Experiments with Col. SK-MM group. Proc. Soc. Exper. Biol. a. Med. 72, 534 (1949).
—: Neuere Ergebnisse über die Pathogenese der Kinderlähmung. Helvet. med. Acta 17, 167 (1950).
—: Further experiments with Col SK murine poliomyelitis virus. Bull. N. Y. Acad. Med. 26, 571 (1950).
—: Neutralization of Col SK and Yale SK virus by polio-eonvalescent and normal human sera. Arch. of Pediatr. 67, 519 (1950).
—: Newer knowledge on the pathogenesis of poliomyelitis. J. of Pediatr. 87, 109 (1950).
—: Chemotherapeutic effects of a naphthoquinonimine on infeetion of mice with Col SK group of viruses. Proc. Soc. Exper. Biol. a. Med. 77, 176 (1951).
—: Experimental Studies with F-virus. Arch Virusforsch. (Wien) 4, 568 (1952).
— and J. Bourdillon: Electronmicrography of murine poliomyelitis virus preparations. J. Amer. Med. Assoc. 123, 399 (1943).
— and G. Dalldorf: Epidemiological and experimental observations on the possible significance of rodents in a suburban epidemic of poliomvelitis. Amer. J. Publ. Health. 88, 169 (1943).
— and G. Dalldorf: Epidemiological and experimental observations of poliomvelitis in New York city (1943–44). Amer. J. Hyg. 43, 49 (1946).
R. R. Feiner and M. Sanders: Studies in rodent poliomyelitis III. Experimental poliomyelitis in guinea pigs produced with the murine strain of SK poliomyelitis virus. J. of Exper. Med. 76, 31 (1942).
— — and B. Horvath: Inhibition of hemagglutination of Columbia SK virus by human polioconvalescent sera. Proc. Soc. Exper. Biol. a. Med. 77, 672 (1951).
— — and A. W. Knox: Inhibition of Col. SK Virus hemagglutination by human saliva. Arch. of Pediatr. 69, 321 (1952).
— — and M. Sanders: Isolation of a murine neurotropic virus by passage of monkey poliomyelitis virus to cotton rats and white mice. Proc. Soc. Exper. Biol. a. Med. 44, 375 (1940).
— —: Studies of a murine strain of poliomyelitis virus in cotton rats and white mice. J. of Exper. Med. 72, 407 (1940).
— —: Studies in rodent poliomyelitis V. Interference between murine and monkey poliomyelitis virus. J. of Exper. Med. 76, 127 (1942).
— — and R. R.: Studies in rodent poliomyelitis. I. Further experiments with the murine strain of SK-virus. J. of Exper. Med. 75, 611 (1942).
— — and E. Steenberg: Neurotropic and viscerotropic strains of Columbia SK and EMC virus. Arch. of Path. 49, 574 (1950).
Keller, W.: Aktuelle Fragen aus dem Gebiet der Poliomyelitis. Med. Ges. Freiburg v. 18.7.1950.
—.: Die Ätiologie und Epidemiologie der abakteriellen Encephalomeningitiden. Mschr. Kinderheilk. 100, 164 (1952).
— u. O. Vivell: Ergänzende Mitteilung zur vorstehenden Arbeit von Hofman und Jung eblut: „Untersuchungen über Neutralisation und Hämagglutinationshemmung von Parapolio- myelitisvirus (Col. SK-Stamm) mit Seren von Fällen von Encephalitis, aseptischer Meningitis und Poliomyelitis. Klin. Wschr. 1952, 1015.
— u. R. Gädeke: Ätiologie und Epidemiologie der abakteriellen Encephalomeningitiden. Wissenschaftl. Ausstellung, 51. Tagg. Dtsch. Ges. Kinderheilk. Heidelberg 1951.
Knox, A. W.: Influence of pregnancy in mice on the course of infeetion with murine poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 73, 520 (1950).
—: Infeetion and Immunity on offspring of mice inoculated during gestation with murine poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 74, 792 (1950).
Koch, F.: Die Encephalomyokarditis (EMC) und ihre Abgrenzung von der Poliomvelitis. Z. Kinderheilk. 68, 328 (1900).
—: Laruelle et Reijmont: La myocardite de la poliomyelite. Ann. Inst. Pasteur 88, 151 (1952).
Lahelle, O., and F. L. Horsfall: Hemagglutination with the GD VII strain of mouse eneephalomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 71, 713 (1949).
Mac Donald, F.: Haemagglutination with virus of Murray Valley encephalitis. (MVE). Brit. J. Exper. Path. 38, 537 (1952).
Mauer, R.: Untersuchungen über die Hämagglutination von Viren der Parapoliomyelitis-gruppe. Diss. Freiburg 1952.
Melnick, J. L.: Sedimentation of Poliomyelitis virus in sharples centrifuge. J. of Immun. 58, 157 (1946).
—: The poliomyelitis, encephalomyocarditis and Coxsackie groups of viruses. Bacter. Rev. 14, 233 (1950).
—: Poliomyelitis and poliomyelitis-like viruses of man and animals. Ann. Rev. Microbiol. 5, 309 (1951).
Morris, M. C.: The effect of trypsin on hemagglutination by murine encephalomyelitis virus. J. of Immun. 68, 97 (1952).
Murray, F. J., J. F. Scrugham and M. J. Foter: Effect of Congo red on the MM virus. Proc. Soc. Exper. Biol. a. Med. 72, 275 (1949).
Nelis, P., et A. Lafontaine: Action des ultrasons sur la souche MM de la poliomyelite de la souris. C. r. Soc. Biol. (Paris) 144, 458 (1950).
O’Dell, T. H., H. N. Wright and R. N. Bieter: Chemotherapeutic activitv of nucleic acids and high protein diets against the infection caused by the MM virus in mice. J. of Pharmacol. 107, 232 (1953).
Olitsky, P. K., and R. H. Yager: Hemagglutination by Col. SK, Col. MM, Mengo-encephalo- myelitis and encephalomyocarditis viruses. Experiments with other viruses. Proc. Soc. Exper. Biol. a. Med. 71, 719 (1949).
Powell, H. M., et al.: A filtrate with ehemoprophylactic and chemotherapeutic action against MM and Semliki forest viruses in mice. Antibiotics a. Chemother. 2, 432 (1952).
Powell, H. M, and W. A. Jamieson: On the immunity of certain mouse adapted poliomyelitis virus strains when cultivated in embryonated eggs. J. Inf. Dis. 83, 328 (1948).
—, and C. G. Culbertson: Injection of mouse adapted and egg adapted poliomyelitis like virus into white rats. Proc. Soc. Exper. Biol. a. Med. 68, 80 (1948).
Robinson, L.: The effect of heating on MM virus. Ann. Rep. Div. Labor. Res. Albanv 1948.
Rustigian, R., and A. M. Pappenheimer: Myositis in mice following intramuscular injection of viruses of the mouse encephalomyelitis group and of certain other neurotropic viruses. J. of Exper. Med. 89, 69 (1949).
Sabin, A. B., et E. L. Buescher: Unique physico-chemicals properties of japanese B-ence- phalitis virus hemagglutinin. Poe. Soc. Exper. Biol. a. Med. 74, 222 (1950).
—, et E. L. Buescher: Poliomyelitis virus of low virulence in patients with epidemic “summer grippe” or sore throat. Amer. J. Hyg. 49, 176 (1949).
Sanders, M., and C. W. Jungeblut: Studies in rodent poliomyelitis. II. Cultivation of the murine strain SK poliomyelitis virus. J. of Exper. Med. 75, 631 (1942).
Y. Subbakow and R. C. Alexander: An effective antiviral synthetic. Texas Rep. Biol. Med. 6, 385 (1948).
Sanz Ibanez, J.: Poliomyelitis experimental. Trab. Inst. Cajal invest. biol. 86, 137 (1944).
—: Experimentelle Untersuchungen zur Pathogenese der Poliomyelitis. Med. Ges. Marburg v. 18. 6. 1952.
Saphir, O.: Visceral lesions in poliomyelitis. Amer. J. Path. 21, 99 (1945).
—: Encephalomyocarditis. Circulation (New York) 6, 843 (1952).
—. and S. A. Wile: Myocarditis in poliomyelitis. Amer. J. Med. Sci. 208, 781 (1942).
Schatz, A., and H. Plager: Effect of pn on MM virus. Proc. Soc. Exper. Biol. a. Med. 67, 452 (1948).
Schmidt, E. C. H.: Virus myocarditis. Pathologie and experimental studies. Amer. J. Path. 24, 97 (1948).
Schmidt-Kessen, W.: Elektrokardiogramm nach Poliomyelitis. Z. inn. Med. 4, 250 (1949).
Schmidt-Kessen, W.: Myokarditis bei Poliomyelitis. Z. inn. Med. 7, 177 (1952).
Schmitt, E.: Untersuchungen an menschlichen Seren mit einer neuen Hämagglutinationshem- mungsreaktion gegen Viren der Parapoliomyelitisgruppe. Diss. Freiburg 1951.
—, M. Buck and N. Steiger: Chemotherapeutic effect of 2 hydroxyl 1,4 naphthoquinonimine on infections of mice with Col. SK virus. Proc. Soc. Exper. Biol. a. Med. 77, 182 (1951).
—, and J. B. Enright: Cultivation of the murine SK strain of poliomyelitis virus in developing eggs. Proc. Soc. Exper. Biol. a. Med. 68, 8 (1946).
—, and J. B. Enright:and C. White: Infeetivity of murine SK-strain of poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 67, 266 (1948).
Schulz-Ehlbeck, H. W.: Experimentelle Untersuchungen über das Verhalten von murinem Poliomyelitisvirus in Zecken (Ornithodorus moubata). Z. Tropenmed. 3, 472 (1952).
—:Beitrag zur Frage der Virusinaktivierung. Klin. Wschr. 1958, 527.
Seligmann, E., and C. W. Jungeblut: Neutralization of SK murine poliomyelitis virus and of Theilers virus of mouse encephalomyelitis by human sera. Amer. J. Publ. Health 38, 1326 (1943).
Shean, D. B., and E. W. Schultz: Comparative tissue explant requirements of Col. SK, C(M) and MM viruses and of Theiler’s encephalomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 73, 622 (1950).
Siegel, B. V.: Further observations on cold hemagglutinin activity in encephalomyocarditis, MM, Mengo-encephalomyelitis and Columbia SK immune sera. Proc. Soc. Exper. Biol. a. Med. 77, 554 (1951).
Sickles, G. M.: Effect of serum of normal animals on MM virus. Ann. Rep. Div. Labor. Res. Albany 1948.
—.: Die Differentialdiagnose der akuten Poliomyelitis mit Hilfe von Laboratoriumsuntersuchungen. 2. Internat. Poliomyelitis-Konf. Kopenhagen 1951.
— and J. Warren: The virus of encephalomyocarditis and its apparent causation of disease in man. J. Clin. Invest. 26, 1197 (1947).
Smithburn, K. C.: Studies on certain viruses isolated in tropics of Africa and South America. Immunological reactions as determined by cross neutralization tests. J. of Immun. 68, 441 (1952).
—: Neutralizing antibodies against eertain recently isolated viruses in sera of human beeings residing in East Africa. J. of Immun. 69, 223 (1952).
Sommers, S. C., J. C. Wilson and F. W. Hartman: Lymphoid lesions in poliomyelitis. J. of Exper. Med. 93, 505 (1951).
Spain, D. M., Y. Bradess and V. Parsonnet: Myocarditis in poliomyelitis. Amer. Heart J. 40, 336 (1950).
Steigman, A. J., and T. V. Kokko: Recovery of type I (Brunhilde) poliomyelitis virus froin mouse brain and spinal cord. Proc. Soc. Exper. Biol. a. Med. 81, 261 (1952).
—., T. V. Kokko and R. J. Sil Verberg: Mack Virus. Serum and gamma globulin neutralization of unidentified agent isolated from suspected nonparalytic poliomyelitis. Proc. Soc. Exper. Biol. a. Med. 83, 200 (1953).
Toomey, J. A., and W. S. Takacs: J. Bacter. 43, 87 (1942); zit. nach Jungeblut.
Steigman, A. J., and T. V. Kokko: Specific neutralization of cotton rat strains of poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 47, 123 (1941).
Verlinde, J. D.: A comparative study on muscular involvement in experimental poliomyelitis induced by various strains of virus and the effect of Hyaluronidase on the intramuseular inoculation. Arch. Virusforsch. (Wien) 4, 546 (1952).
—: An experimental study on the effect of immunization with T. A. B. and pertussis Vaccine and aluminium preeipitated diphtheria toxoid on the centripetal and centrifugal spread of poliomyelitis virus. Arch Virusforsch. (Wien) 4, 561 (1952).
— et P. de Baan: Sur l’hemagglutination par des virus poliomyelitiques murins et la destruction eneymatique de reeepteurs de virus poliomyelitique de la cellule reeeptive. Ann. Inst. Pasteur 77, 632 (1949).
B. Beem and A. Klarenbeek: Studies on immunity in poliomyelitis. II. Adaption a of strain of poliomyelitis on mice and immunization experiments with the mouse adapted virus. Leeuwenhoek, J. Microbiol. a. Serol. 18, 364 (1952).
— Klarenbeek and B. Hofman: Pathogenic and immunologic properties of 2 new members of the Col. SKgroup of viruses. Arch. Virusforsch. (Wien) 5, 14 (1952).
—, and A. Klarenbeek: Studies on Immunity in poliomyelitis. I. Homologous immunity produced with ultraviolet irradiated adsorbate Vaccine. Arch. Virusforsch. (Wien) 5; 27 (1952).
—. Klarenbeek and E. Stihoul: Excretion of poliomvelitis virus by healthy contact persons. Nederl. Tijdschr. Geneesk. 94, 1186 (1950).
—, and H. A. E. van Tongeren: Human infections with viruses of the Columbia SK group. Arch. Virusforsch. (Wien) 5, 217 (1953).
—: Experimentelle Untersuchungen zur Virusinterferenz. Tagg. Südwestdtsch. Kinderärzte, Tübingen 1950.
—: Experimentelle Untersuchungen zur Selbstinterferenz des MM-Virus. Z. Kinderheilk. 70, 113 (1951).
—: Über Interferenzerscheinungen bei Infektionskrankheiten. Erg. imi. Med. N. F. 2, 680 (1951).
—: Über eine serologische Methode zum Nachweis einer Infektion mit murinen Poliomyelitisviren. Mschr. Kinderheilk. 100, 175 (1952).
Gerstner, A., u. K. Yolageldili: Untersuchungen über die Hämagglutination von Viren der Parapoliomyelitisgruppe. III. Mitteilung. Zur Frage der Spezifität des Hämagglutina- tionshemmungstestes sowie weitere Ergebnisse serologischer Studien. Z. Immun.forsch. 109, 527 (1952).
—, u. R. Mauer: Untersuchungen über die Hämagglutination von Viren der Parapoliomyelitisgruppe (Encephalomyokarditisgruppe). I. Mitteilung. Zur Charakteristik des Hämagglu- tinationsphänomens. Z. Immun.forsch. 109, 246 (1952).
—, E. Schmitt u. A. Gerstner: Untersuchungen über die Hämagglutination von Viren der Parapoliomyelitisgruppe (Eneephalomyokarditisgruppe). II. Mitteilung. Über einen neuen Hämagglutinationshemmungstest nach der Methode von Hirst. Ergebnisse serologischer Untersuchungen. Z. Immun.forsch. 109, 274 (1952).
Warren, J.: Encephalomyocarditis in Rivers: Viral and rickettsial infections of Man. Philadelphia: Lippincott Comp. 1948.
—: Viruses of the encephalomyocarditis group. Ann. N. Y. Acad. Sci. 56, 609 (1953).
— and J. E. Smadel: A serological relationship between the virus of encephalomyocarditis and certain strains of poliomyelitis viruses. Federat. Proc. 7, 311 (1948).
—: Further observations on the virus of EMC. J. Baeter. 51, 615 (1946).
— and S. B. Russ: The family relationship of encephalomyocarditis, Columbia SK, MM and Mengo-encephalomyelitis viruses. J. of Immun. 62, 387 (1949).
—, S. B. Russ and H. Jeffries: Neutralizing antibody against viruses of the encephalomyocarditis group in the sera of wild rats. Proc. Soc. Exper. Biol. a. Med. 71, 376 (1949).
Wolf, A.: Studies in rodent poliomyelitis. IV. The pathology of murine and cavian poliomyelitis. J. of Exper. Med. 76, 53 (1942).
Wood, H. G. and J. J. Rusoff: Protective action of trypan red against infection by neurotropic virus. J. of Exper. Med. 82, 297 (1945).
Yager, R. H.: Hemagglutination by GD VII and Col. SK, Col. MM, Mengo-encephalomyelitis and the EMC-group of neurotropic viruses. Federat. Proc. 10, 579 (1951).
K. L. Kuttler, P. Olitsky and L. C. Murphy: Hemagglutination by neurotropic viruses. U. S. Army Force Med. J. 1, 920 (1950).
Pseu dopoliomyelitis.
Pseudopoliomyelitis
Adams, J. M., R. A. Boak, C. M. Carpenter, J. D. French, S. J. Klein, J. J. Pressman and J. L. Smith: Prevention of paralytic poliomyelitis in tonsilleetomized eynomolgus monkeys by human gamma globulin. J. Labor, a. Clin. Med. 41, 142 (1953).
Alm, L.: The Coxsackie viruses, presented at the Staff Conference, Army Med. Service Graduate School Washington, D. C. 22. Nov. 1950.
Armstrong, N. P., F. H. Wilson, W. J. Mc Lean, N. Silverthorne, E. M. Cläre, A. J. Rhodes, D. S. Knowles, R. C. Ritchie and W. L. Donohue: Studies on Poliomyelitis in Ontario. II. Isolation of Coxsackievirus in association with poliomyelitis virus. Preliminary report. Canad. J. Publ. Health 41, 51 (1950).
Atkinson, N.: Med. J. Austral. 1, 813 (1951).
J. Dineen and J. S. Robertson: A pleurodynia virus pathogenic for infantmice. Austral. J. Exper. Biol. 29, 463 (1951).
Baggio, C.: Epidemia familiare di pleurodinia. Acta paediatr. Lat. 4, 321 (1951).
Banker, D.D., and J. L. Melnick: Isolation of Coxsackie (C-Virus) from North Alaskan Eskimos. Amer. J. Hyg. 54, 383 (1951).
Beeman, E. A., R. M. Cole and R. J. Huebner: Studies in man of neutralizing antibodies against group A Coxsackie (Herpangina) viruses. Prevalence of antibodies in Community in 1949 and 1950. Amer. J. Hyg. 56, 216 (1952).
— and R. J. Huebner: Evaluation of serological methods for demonstrating antibody responses to group A Coxsackie (Herpangina) viruses. J. of Immun. 68, 663 (1952).
— and R. M. Cole: Studies of Coxsackie viruses: Laboratorv aspects of group A viruses. Amer. J. Hyg. 55, 83 (1952).
R. H. Parrot and R. M. Cole: Simultaneous occurence of 2 immunological types of group A Coxsackie virus in a case of Herpangina. Proc. Soc. Exper. Biol. a Med, 78, 295 (1951).
Berger, E., E. Freudenberg u. F. Roulet: Zur Kenntnis der Coxsackie-Virus (C-Virus) - Infektion. Ann. paediatr. (Basel) 179, 65 (1952).
— u. F. Roulet: Beiträge zur Ausscheidung und Tierpathogenität des Coxsackie-Virus. Schweiz. Z. Path. 15, 462 (1952).
Bernkopf, H.: Foreign letters. J. Amer. Med. Assoc. 145, 1215 (1951).
Betke, K., H. Richarz, H. Schubothe u. O. Vivell: Beobachtungen zu Kranklieitsbild, Pathogenese und Ätiologie der akuten erworbenen hämolytischen Anämie (Lederer- Anämie). Klin. Wschr. 1958, 373.
Bieling, R.: Die Bornholmer Krankheit und das Coxsackie-Virus. Dtsch. med. Wschr. 195 489.
—: Die Europäische Welle von Coxsackie-Virus-Infektionen. Dtsch. med. Wschr. 1952, 1029.
Bingel, K. F., u. M. Schuster: Klinische, ätiologische und epidemiologische Untersuchungen über eine epidemische Virusmeningitis. Dtsch. med. Wschr. 1950, 1652.
Boak, R. A., B. F. Klausmann and C.B. Ward: Coxsackie Virus in southern California. Isolation of a strain from stools of a patient. Calif. Med. 77, 187 (1952).
Bodian, D.: Differentiation of types of poliomyelitis viruses. I. Reinfection experiments in monkeys (seeond attaeks). Amer. J. Hyg. 49, 200 (1949).
J. M. Morgan and H. A. Howe: Differentiation of types of poliomyelitis viruses. III. The grouping of 14 strains into three basie immunological types. Amer. J. Hyg. 49, 234 (1949).
Breese, S. S., and A. Briefs: Certain physieal properties of herpangina strain and a pleurodynia strain of Coxsackie virus. Proc. Soc. Exper. Biol. a. Med. 83, 119 (1953).
Briefs, A., B. B. Breese, J. Warren and R. J. Huebner: Physieal properties of 2 group A Coxsackie (Herpangina) viruses when propagated in eggs and mice as determined by ultracentrifugation and electron microscopy. J. Bacter. 64, 237 (1952).
Brown, C., D. C. Little and J. O’H. Tobin: Bornholm disease and Coxsackie virus. Lancet Nr. 6705, 445 (1952).
Buhn, H. W.: Serologische Reihenuntersuchungen mit dem SABiN-FELDMANschen Serofarbtest auf Toxoplasmose bei Schwangeren und Wöchnerinnen (zugleich ein Beitrag zur diaplacentaren Übertragung der Toxoplasmoseantikörper). Diss. Freiburg 1952.
O. Vivell u. H. Richarz: Zur Frage der diaplacentaren Übertragung der Toxoplasmoseantikörper sowie zur Kasuistik der konnatalen Toxoplasmose. Mschr. Kinderheilk. 100, 400 (1952).
Burnet, F. M.: Med. J. Austral. 27, 325 (1940); zit. nach R. Doerr, Die Immunitätsforschung. Ergebnisse und Probleme in Einzeldarstellungen, Bd. 4, Antikörper. 2. Teil. Wien: Springer-Verlag 1949.
Bury, H. S., and J. O’H. Tobin: Further outbreak of Bornholm disease associates with Coxsackie Virus. Lancet Nr. 6728, 267 (1952).
Carpenter, C. M., and R. A. Boak: Coxsackie viruses. Review of pathologic, epidemiologie, diagnostic and etiologic observations. Calif. Med. 77, 127 (1952).
Casals, J.: Acetone-ether extracted antigens for complement fixation with certain neurotropic viruses. Proc. Soc. Exper. Biol. a. Med. 70, 339 (1949).
Casals, J. and P. K. Olitsky: Complement fixation tests with some viruses of the Coxsackie group. Federat. Proc. 9, 570 (1950).
Casals, J. and P. K. Olitsky: The adaption of poliomyelitis virus, Lansing strain, to newborn mice and the use of their central nervous system for preparation of antigen. Arch. Virusforsch. (Wien) 4, 452 (1951).
Casals, J. and L. C. Murphy: Hemagglutination and complement fixation with type I and II Albany strains of Coxsackie viruses. Proc. Soc. Exper. Biol. a. Med. 72, 636 (1949).
Cheever, S., J. B. Daniels and H. E. Freeman: A viral agent isolated from a case of non- paralytie poliomyelitis and pathogenie for suekling mice. Its possible relation to the Coxsackie group of viruses. J. of Exper. Med. 92, 153 (1950).
Christen, J. P.: A propos du virus de Coxsackie. Rev. med. Suisse rom. 72, 724 (1952).
Casals, J. and P. K. Olitsky: A propos d’affeetions ä Coxsackie. Ami. paediatr. (Basel) 180, 279 (1953).
Clark, E. M., D. S. Knowles, F. S. Shimada, A. J. Rhodes, R. C. Ritchte and W. L. Donohue: Coxsackie virus in urban sewage. Recovery of virus in season of low incidence of reported poliomyelitis. Canad. J. Publ. Health 42, 103 (1952).
Coffey, J. M.: Electron microscopy of the Coxsackie virus. Annual Rep. N. Y. State Dep. Health 1949, 10.
Cole, R. M.: Herpangina and the Coxsackie viruses. New England J. Med. 245, 627 (1951).
J. A. Bell, E. A. Beeman and R. J. Huebner: Studies of Coxsackie viruses. Observations on epidemiological aspects of group A viruses. Amer. J. Publ. Health 41, 1342 (1951).
Contreras, G., V. H. Barnett and J. L. Melnick: Identification of Coxsackie viruses by immunological methods and their Classification into 16 antigenically distinet types. J. of Immun. 69, 395 (1952).
van Crefeld, S.: La maladie de Bornholm. Arch. fran§. Pediatr. 9, 689 (1952).
Curnen, E. C.: Human disease associated with the Coxsackie viruses. Bull. N. Y. Acad. Med. 26, 335 (1950).
—:Immunology and clinieal aspects of Coxsackie virus infections. 2. Internat. Poliomyelitis- Conference Copenhagen 1951.
— and M. O. Godenne: Differentiation of infeetion by Coxsackie and Herpes simplex viruses. Amer. J. Dis. Childr. 85, 645 (1953).
Zit. nach Curnen, E. C. Immunology and clinical aspects of Coxsackie virus infections. 2. Internat. Poliomyelitis Conference Copenhagen 1951.
——: Poliomyelitis- and Coxsackie viruses in paralytic poliomyelitis. Pediatrics 8, 237 (1951).
Coxsackie- and Poliomyelitis-viruses in paralytic poliomyelitis. Soc. Pediatr. Research, Atlantic City, May 1951.
E. W. Shaw and J. L. Melnick: Disease resembling nonparalytic poliomyelitis associated with a virus pathogenie for infant- mice. J. Amer. Med. Assoe. 141, 894 (1949).
Dahlström, E. A.: Coxsackie virus infection. Report of two cases. Acta paediatr. (Stockh.) 40, 235 (1951).
Dalldorf, G.: The etiology of poliomyelitis. N. Y. State J. Med. 49, 2053 (1949).
—: The Coxsackie group of viruses. Westchester Med. Bull. 17, 14 (1949).
—: Suggested studies of poliomyelitis. N. Y. State J. Med. 49, 1330 (1949).
—: The Coxsackie viruses. Proc. N. Y. State Assoc. Publ. Health Labor. 29, 54 (1949).
—: The Coxsackie group of viruses. Science (Lancaster, Pa.) 110, 594 (1949).
—: The Coxsackie viruses. Amer. J. Publ. Health 40, 1508 (1950).
—: The Coxsackie viruses. Bull. N. Y. Acad. Med. 26, 329 (1950).
—: The Coxsackie viruses. Science (Lancaster, Pa.) 112, 422 (1950).
—: The sparing effect of Coxsackie virus infection on experimental poliomyelitis. J. of Exper. Med. 94, 65 (1951).
—: Die Coxsackie-Viren, ihre Isolierung und Charaktereigenschaften. 2. Internat. Poliomyelitis-Konferenz, Kopenhagen 1951.
—: From Clostridium Welchii to the Coxsackie viruses: Changing microbiology. J. Mount Sinai Hosp. 19, 396 (1952).
—: Los virus Coxsackie. Aislamiento y propiedades. Medieina, Rev. Mexic. 82, 244 (1952).
—: Die Viren der Coxsackiegruppe. Münch, med. Wschr. 94, 2113 (1952).
—: The Coxsackie virus group. Ann. N. Y. Acad. Sci. 56, 583 (1953).
— and M. Douglass: Simultaneous distemper and lymphocytic ehoriomeningitis in dog spieen and the sparing effect on poliomyelitis. Proc. Soc. Exper. Biol. a. Med. 39, 294 (1938).
— and H. E. Robinson: The sparing effect of canine distemper on poliomyelitis in macaca mulatta. J. of Exper. Med. 67, 333 (1938).
—: The Coxsackie viruses. Annual Rep. Div. Labor. N. Y. State Dep. Health 1951.
—: Tentative Classification of Coxsackie virus into group A and B on the basis of differenees in the character of the experimental disease. Presented eastern New York Branch Soc. Amer. Bacter. 1950.
—: Clinical and epidemiologic observations of Coxsackie virus infection. New England J. Med. 244, 868 (1951).
—: Adaption of group B Coxsackie virus to adult mouse pancreas. J. of Exper. Med. 96, 491 (1952).
—. and G. M. Sickles: An unidentified filtrable agent isolated from the feces of children with paralysis. Science (Lancaster, Pa.) 108, 61 (1948).
H. Plager and R. Gifford: A virus recovered from the feces of poliomyelitis patients pathogenic for suckling mice. J. of Exper. Med. 89, 567 (1949).
— and R. Gifford:Coxsackie group of viruses. Annual Rep. Div. Labor. N. Y. State Dep. Health 1950.
David, J. K., D. Leavitt and B. F. Howitt: Vesicular Pharyngitis, its relationship to the Coxsackie group of viruses. Pediatrics 8, 672 (1951).
Dean, D. J.: The response of certain domesticated animals to injections of Coxsackie, MM- and Theiler-viruses. Annual Rep. Div. Labor. N. Y. State Dep. Health, 1951.
Delpy, M. J.: Preparation d’un antigene purifie (protamine ether) pour la Serologie des affections du groupe Coxsackie. Presse med. 61, 674 (1953).
Desse, M. G.: Maladie de Bornholm. Ligue frant. contre le rhumatisme. Sitzg. v. 13. 2. 1952.
—: Maladie de Bornholm. Rev. rhumat. 19, 297 (1952).
—: Maladie de Bornholm. Semaine Hop. 29, 482 (1953).
Dodd, R. L.: Complement fixation with the Coxsackie viruses. Annual Rep. Div. Labor. N. Y. State Dep. Health, 1951.
Doerr, R.: Die Immunitätsforschung. Ergebnisse und Probleme in Einzeldarstellungen. Band IV, Antikörper, 2. Teil. Wien: Springer-Verlag 1949.
Dolder: Pleuritis sicca epidemica. Korrespbl. Schweiz. Ärzte 9, 586 (1879).
Dorn, H. H.: Untersuchungen über das Vorkommen von Coxsackie-Virus-Infektionen in Deutschland. Diss. Freiburg 1952.
Duncan, P. R., A. E. Thomas and J. O’H. Tobin: Lymphocytic ehoriomeningitis. Review of ten cases. Lancet 1951, 956.
Elliott, R. G.: Coxsackie virus. Kentucky Med. Assoc. J. 50, 340 (1952).
Enders, J. F.: Vermehrung und Eigenschaften der Poliomyelitisviren auf menschlichen Gewebskulturen. 2. Internat. Poliomyelitis-Konferenz, Kopenhagen 1951.
Farmer, T. W., G. P. Manire and S. E. Sulkin: Infections with Coxsackie virus observed during epidemic of poliomyelitis in Texas in 1949. Amer. J. Med. 9, 398 (1950).
Farmer, T. W., G. P. Manire and S. E. Sulkin: The association of Coxsackie viruses with Poliomyelitis and other human infections. Trans. Amer. Neur. Assoc. 76, 137 (1951).
Findlay, G. M., J. A. Anderson and M. H. K. Hagie: Poliomyelitis in West-Africa. J. Rov. Army Med. Corps 86, 20 (1946).
—, and E. M. Howard: Coxsackie viruses and Bornholm disease. Brit. Med. J. 1950, 1233.
—, G. M., and E. M. Howard: The effect of Cortisone and adrenocotrophie hormons in poliomyelitis and other virus infections. J. of Pharmacy a. Pharmacol. 4, 37 (1952).
Pinn, J. J.: Pleurodynie New England J. Med. 237, 621 (1947).
T. H. Weller and H. R. Morgan: Epidemie pleurodynia. Clinical and etiologic studies based on one hundred and fourteen cases. Arch. Int. Med. 83, 305 (1949).
Fischer, R., and J. T. Syverton: The coekroaeh as a experimental vector of Coxsackie virus. Amer. J. Trop. Med. 31, 238 (1951).
Forrester, R. M., and J. O’H. Tobin: The isolation of Coxsackie virus from a case with atypical clinical features. Lancet Nr. 6685, 663 (1951).
Freudenberg, E.: Med. Ges. Basel, Sitzg. v. 25.10. 1951.
—: Zur Klinik der Erkrankungen durch Coxsackie-Virus. Münch, med. Wschr. 1952, 476.
—: Basler kinderärztl. Ges. Sitzg. v. 14. 5. 1952.
F. Roulet u. R. Nicole: Kongenitale Infektion mit Coxsackie-Virus. Ann. paediatr. (Basel) 178, 150 (1952).
Gabinus, O., S. Gard, T. Johnsson and A. Pöldre: Studies on the etiology of epidemic pleurodynia (Bornholm disease). I. Clinical and virologieal observations. Arch. Virusforsch. 5, 1 (1952).
— — — —: Myalgia epidemica und Coxsackie Virus. Sv. Läkartidn. 1952, 2225.
—: Glomeruläre und tubuläre Nephrose der Säuglingsmaus nach Infektion mit Viren der Coxsackie-A-Gruppe. Naturwiss. 39, 71 (1951)
—: Kidney lesions in suekling mice following group A Coxsackie virus infection. Arch. of Path. 54, 276 (1952).
—: Morphologische Grundlagen neuerer Anschauungen über das Krankheitsbild der Poliomyelitis. Virchows Arch. 322, 563 (1952).
—: Vergleichende morphologische und chemische Muskelbefunde bei Säuglingsmäusen und Meerschweinchen nach experimenteller Infektion mit Viren der Coxsackie A-Gruppe. Kim. Wschr. 1952, 1040.
—: Zur Pathogenese der Coxsackie-Virus-Infektionen. Freiburger med. Ges., Sitzg. v. 16. 12. 1952.
— u. H. Waltenberger: Histologische, histochemische und chemische Untersuchungen von Säuglingsmäusen und saugenden Meerschweinchen zur Frage der Pathogenität von Coxsackie-A-Viren. Z. Naturforseh. 7 b, 524 (1952).
— —: An outbreak of benign meningoencephalitis. Isolation of Coxsackie virus. Lancet Nr. 6756, 372 (1953).
Gard, S.: C-Virus som Orsak tili Barnforlamning Utan Pareser. Sv. Läkartidn. 47, 285 (1950).
— and K. Agren: 3. Europäischer Poliomyelitis Kongreß, Amsterdam 1950.
— and T. Johnsson: Studies of Coxsackie viruses. Transact. 10. Scand. Congr. of Path. a. Bact. Acta path. scand. (Copenh.) Suppl. 93, 332 (1952).
Gärtner, K.: Die Bornholmer Krankheit. Dtsch. med. Wschr. 1952, 131.
Gear, J. H. S.: La poliomyelite en Afrique du Sud. Semaine Hop. 27, 1043 (1951).
— and B. Mündel: Studies in poliomyelitis: Study of outbreak of poliomyelitis occuring in a suburb of Johannesburg. S. Afric. Med. J. 20, 106 (1946).
Geffen, T.: Bornholm disease. Brit. Med. J. 1951, 1185.
Gifford, R.: Experiences with the Coxsackie virus. Presented 4. Ann. Sess. Massachusetts, Publ. Health Conf. June 14, 1950.
— and G. Dalldorf: Creatinine, potassium and virus content of the muscles following infection with the Coxsackie virus. Proc. Soc. Exper. Biol. a. Med. 71, 589 (1949).
—: The morbid anatomy of experimental Coxsackie virus infection. Amer. J. Path. 27, 1047 (1951).
Godenne, M. O., and E. C. Curnen: Propagation of Coxsackie virus on the chorioallantoic membrane of embryonated eggs. Proc. Soc. Exper. Biol. a. Med. 81, 81 (1952).
Godman, C. G., H. Bunting and J. L. Melnick: The histopathology of Coxsackie virus infection in mice. I. Morphologie observations with 4 different viral types. Amer. J. Path. 28, 223 (1952).
Gruner, E. H.: Die Bornholmsche Krankheit und ihre Beziehungen zur Poliomyelitis. Arch. Kinderheilk. 145, 146 (1952).
Gsell, O.: Meningitis myalgica. Schweiz, med. Wschr. 1949, 241.
Himmelweit, F., G. M. Findlay and E. M. Howard: The size of Coxsackie viruses as estimated by filtration through gradoeol membranes. J. of Exper. Path. 31, 809 (1950).
Hirst, G. K.: The agglutination of red cells by allantoic fluid of chick embryo infeeted with influenza virus. Science (Lancaster, Pa.) 94, 22 (1941).
Hodes, H. L., H. D. Zepp and A. L. Florman: Isolation of a virus (not previously described) causing encephalitis in mice. Soc. pediatr. Research. Atlantic City, May 1951.
Horsfall, F. L.: Diagnosis of viral and rickettsial infections. New York Columbia University Press 1949.
Horstmann, D. M.: PoMomyelitis virus in blood of orally infected monkeys and chimpanzees. Proc. Soc. Exper. Biol. a. Med. 79, 417 (1952).
Howard, T., C. A. Weymüller, J. Edson, E. Ittner, J. Watson and M. L. Cassidy: Epidemie pleurodynia in Brooklyn in the summer of 1942. J. Amer. Med. Assoc. 21, 925 (1943).
Howes, D. W.: The relationship of age to the susceptibility of mice to two viruses of the Coxsackie group. Austral. J. Exper. Biol. 30, 423 (1952).
—:Virus isolated from case resembling epidemic pleurodynia. Preliminary report. Med. J. Austral. 2, 597 (1951).
Howitt, B. F.: Recovery of the Coxsackie group of viruses from human sources. Proc. Soc. Exper. Biol. a. Med. 78, 443 (1950).
—:Isolation and differentiation of Coxsackie group of viruses. Federat. Proc. 9, 574 (1950).
—:and U. R. Benefield: Use of complement fixation in differentiation of strains of Coxsackie virus. Proc. Soc. Exper. Biol. a. Med. 73, 90 (1950).
—.:and U. R. Benefield, and V. J. Nichols: Inoculation of eynomolgus monkeys with Coxsackie viruses alone, combined, or with poliomyelitis virus. Presented bef. the Laborat. Section. Ann. Publ. Health Assoc. St. Louis, Nov. 1950.
—and U. R. Benefield:Inoculation of eynomolgus monkeys with Coxsackie viruses alone, combined, or with poliomyelitis virus. J. of Immun. 68, 599 (1952).
Huebner, R. J., C. Armstrong, E. A. Beeman and R. M. Cole: Studies of Coxsackie viruses. Preliminary report on oecurence of Coxsackie virus in southern Maryland Community. J. Amer. Med. Assoc. 144, 609 (1950).
E. A. Beeman, R. M. Cole, P. M. Betgelman and J. A. Bell: The importance of Coxsackie viruses in human disease, particularly Herpangina and epidemic pleurodvnia. New England J. Med. 247, 249, 285 (1952).
R. M. Cole, E. A. Beeman and J. A. Bell: Herpangina. Etiological studies of a specific infeetious disease. J. Amer. Med. Assoc. 145, 623 (1951).
S. R. Ranson and E. A. Beeman: Studies of Coxsackie virus. Adaption of a strain to chick embryos. Publ. Health Rep. 65, 803 (1950).
J. H. Risser, J. A. Bell, E. A. Beeman, F. M. Beigelman and J. C. Strong: Epidemic pleurodynia in Texas. A study of 22 cases. New England J. Med. 248, 267 (1953).
Hurblut, H. S.: The recovery of poliomyelitis virus after parenteral introduetion into coekroaehes and houseflies. J. Inf. Dis. 86, 803 (1950).
Jackson, F. W.: Canad. J. Publ. Health 28, 363 (1937); zit. nach Doerr, R. Die Immunitätsforschung. Ergebnisse und Probleme in Einzeldarstellungen. Band 4, Antikörper, 2. Teil, Wien: Springer-Verlag 1949.
Jaworski, A. A., and E. J. West: Aseptic meningitis of new virus origin. J. Amer. Med. Assoc. 141, 902 (1949).
Johnsson, T., and J. Lindahl: Herpangina. A clinical and virological study. Arch. Virusforsch. (Wien) 5, 96 (1953).
Jungeblut, C. W.: Further observations of the poliocidal property of pregnant mare serum. Proc. Soc. Exper. Biol. a. Med. 33, 137 (1935).
—: Neutralization of Col. SK and Yale SK virus by polio-eonvalescent and normal human sera. Arch. of Pediatr. 67, 519 (1950).
Ivanovics, G., and M. Pinter: Coxsackie virus infection in Hungary. Acta med. Acad. Sci. 4, 157 (1953).
Kausche, G. A., u. H. Hofmann-Berling: Die Nucleinsäureverteilung in mit Coxsackievirus beimpften Mäusemuskeln. Z. Naturforsch. 7 b, 518 (1952).
C. Landschütz u. R. Sauthoff: Histochemischer Nachweis von alkalischer Phosphatase am Mäusemuskel nach Infektion mit dem Coxsackie-Virus. Z. Naturforsch. 6 b, 445 (1950).
Kaplan, A. S., and J. L. Melnick: Oral administration of Coxsackie viruses to newborn and adult mice. Proc. Soc. Exper. Biol. a. Med. 76, 312 (1951).
Keller, W.: Das Coxsackie-Virus, eine neuentdeckte Gruppe von Krankheitserregern. Umschau 50, 669 (1950).
—:Kinderlähme kein einheitlicher Begriff. Umschau 52, 568 (1952).
—:Die Ätiologie und Epidemiologie der abakteriellen Encephalomeningitiden. Mschr. Kinderheilk. 1952, 164.
— —: Über das Vorkommen von Coxsackie-Virus-Infektionen in Deutschland. Klin. Wschr. 1951, 744.
—:Weitere Untersuchungen über das Vorkommen von Coxsackie-Virus-Infektionen in Deutschland. Klin. Wschr. 1952, 289.
—:Bemerkungen zur Arbeit von W. Klöne: „Untersuchungen über Antikörper gegen Coxsackie-Viren.”Dtsch. med. Wschr. 1952, 1030.
Keller, W., u. O. Vivell: Die Bedeutung der Viren der Coxsackie-Gruppe. Freiburger med. Ges., Sitzg. v. 16. 12.1952.
Kenyon, H., A. D. Macrae and R. J. Dodds: Outbreak of febrile illness associated with Coxsackie virus. Lancet Nr. 6726, 153 (1952).
Kessel, J. K., and C. F. Pait: Differentiation of 3 groups of poliomyelitis virus. Proc. Soc. Exper. Biol. a. Med. 70, 315 (1949).
— —: Immunologie groups of poliomyelitis virus. Amer. J. Hyg. 51, 76 (1950).
—: Diverse manifestations of infection with a strain of Coxsackie virus. Federat. Proc. 9, 581 (1950).
—:The Coxsackie viruses and human disease. Amer. J. Med. Sci. 224, 93 (1952).
—and F. L. Horsfall: Lethal infection with Coxsackie virus of adult mice given Cortisone. Proc. Soc. Exper. Biol. a. Med. 77, 135 (1951).
Klöne, W.: Untersuchungen über Antikörper gegen Coxsaekie-Virus. Dtsch. med. Wschr. 1952,181.
Kraft, L. M.: Occurence of Coxsackie virus eomplement fixing antibodies in sera of normal monkeys. Proc. Soc. Exper. Biol. a. Med. 80, 498 (1952).
— and J. L. Melnick: Plate eomplement fixation test and its application to the Coxsackie viruses. Federat. Proc. 9, 385 (1950).
—:and J. L. Melnick:Immunological reactions of the Coxsackie viruses. III. The eomplement fixation test. J. of Exper. Med. 92, 483 (1950).
—:and J. L. Melnick:Complement fixation tests with homologous and heterologous types of Coxsackie virus in man. J. of Immun. 08, 297 (1952).
—:and J. L. Melnick:Quantitative studies of the virus-host relationship in ehimpanzees after inapparent infection with Coxsackie viruses. II. The development of eomplement fixing antibodies. J. of Exper. Med. 97, 401 (1953).
—: Herpangina: Clinical and laboratory aspects of an outbreak caused by group A Coxsackie viruses. Pediatrics. 11, 113 (1953).
K. Hummeler and M. M. Sigel: Herpangina. Laboratory aspects of infection with Coxsackie viruses. Bacter. Proc. 1952, 105.
— and M. M. Sigel:Clinical and etiological studies of Herpangina in Philadelphia. Amer. J. Dis. Childr. 84, 505 (1952).
Kunz, L. J., S. Richardson and A.M. Pappenheimer: Pancreatic disease in mothers of suckling mice infected with Connecticut 5 strain of Coxsackie virus. Proc. Soc. Exper. Biol. a. Med. 79, 488 (1952).
Lacorte, G.: O virus de Coxsackie. Rev. Brasil. Med. 8, 850 (1951).
Lacroix, A., J. Bonnet et H. Jonanneau: Existe-t-il une viro-epidemie algeroise; maladie de Bornholm; virus de Coxsackie? Soc. med. Hop. d’Alger v. 19. 6. 1952.
Landsteiner, K., u. E. Popper: Mikroskopische Präparate von einem menschlichen und 2 Affen-Rückenmarken. Wien. klin. Wschr. 1908, 1830.
— —:Übertragung der Poliomyelitis acuta auf Affen. Z. Immun.forsch. 2, 377 (1909).
Laruelle et Reumont: La myoeardite de la poliomyelite. Ann. Inst. Pasteur 83, 151 (1952).
Lawson, R. B.: Coxsackie virus, a recently described agent associated with febrile illnesses in man and eausing myonecrosis in suckling mice. 6. Internat. Kongr. f. Pädiatrie, Zürich 1950.
Lazarus, A. S., E. A. Johnston and J. E. Galbraith: Association of group B Coxsackie viruses with outbreak of epidemic pleurodynia. Bacter. Proc. 1951, 95.
— — and J. Galbraith: An outbreak of epidemic pleurodynia with special reference to the laboratory diagnosis of Coxsackie virus infections. Amer. J. Publ. Health 42, 20 (1952).
Ledinko, N., J. T. Riordan and J. L. Melnick: Multiplication of poliomyelitis virus in tissue cultures of monkey testes. I. Growth curves of type 1 (Brunhilde) and type 2 (Lansing) strains and description of a quantitative neutralization test. II. Direct isolation and typing of strains from human stools and spinal cords in roller tube. Amer. J. Hyg. 55, 323 (1952).
Lennette, E. H.: Zit. nach Dalldorf, G., Die Viren der Coxsackie-Gruppe. Münch, med. Wschr. 1952, 2113.
Lepine, P., L. Chaumont et J. Blusson: Sensibilite du merion aux virus ä Coxsackie. Presse med. 60, 755 (1952).
G. Desse et V. Sautter: Biopsies musculaires avec examen histologique et isolement du virus Coxsackie chez l’homme atteint du myalgie epidemique (maladie de Bornholm). Bull. Acad. Med. (Paris) 186, 66 (1952).
V. Sautter, M. J. Delpy et F. Artzet: Technique de la deviation du complement sur plaques dans les maladies ä virus. Application aux virus de la groupe Coxsackie. Presse med. 61, 674 (1953).
V. Sautter, M. J. Delpy et F. Artzet: Technique de la deviation du complement sur plaques dans les maladies ä virus Application aux virus du groupe Coxsackie. Ann. Inst. Pasteur 84, 684 (1953).
Lepine, P., V. Sauttee et L. Reinte: Hernies abdominales chez les souriceaux inocules avec le virus Coxsackie. Ann. Inst. Pasteur 82, 251 (1952).
S. Thieffry, L. Reinie, V. Sauttee, et R. Martin: Presenee en France d’infections humaines du groupe Coxsackie (virus C). Isolement du virus. Ann. Inst. Pasteur 80, 200 (1951).
Levaditi, C.: Un nouvel ultra virus (Coxsackie) associe a eelui de la poliomyehte. Semaine Hop. 1950, 4541.
—:La coelogenese nevraxique du virus Coxsackie. Ann. Inst. Pasteur 81, 260 (1951).
—et. J. Henry-Eveno: Affinites neurotropes de la souche Coxsackie B et myotropes de la souche A type 1 du meme virus chez les souriceaux nouveau nes. Presse med. 60, 774 (1952).
—:Antagonisme entre le virus de l’encephalomyelite est et celui de la maladie de Bornholm. Presse med. 60, 1051 (1952).
—:Affinites neurotropes de la souche Coxsackie B et myotropes de la souche A type 1 du meme virus chez les souriceaux nouveau nes. Ann. Inst. Pasteur 82, 751 (1952).
—:Le virus Coxsackie B (type eneephalitogene) et la «Borrelia duttoni» sont-ils sus- ceptibles de creer un etat de symbiose ? Presse med. 61, 136 (1953).
—:Virus Coxsackie (souche eneephalitogene B) et neoplasmes de la souris. Presse med. 61, 513 (1953).
—:Symbiose entre le virus Coxsackie souche B neutrope et celui du louping ill. Presse med. 61, 674 (1953).
—:et A. Vaisman: Relations entre les virus Coxsackie et poliomyehte. Ann. Inst; Pasteur 80,. 678 (1951).
—:et A. Vaisman:Y-ä-til possibilite de symbiose entre le virus Coxsackie et eelui de l’encephalite Theiler ? Ann. Inst. Pasteur 81, 207 (1951).
—:et A. Vaisman:Symbiose entre le type B eneephalitogene du virus Coxsackie et celui de la fievre aphtheuse neurotrope. Ann. Inst. Pasteur 81, 210 (1951).
— et F. Dunoyer: Sort du virus eneephalitogene Coxsackie inoeule dans l’eneephale des souris adultes. C. r. Acad. Sci. (Paris) 233, 1148 (1951).
—:Symbiose des virus Coxsackie et Nieholas Favre. C. r. Acad. Sci. (Paris) 233, 1234 (1951).
— et J. Henry-Eveno: Symbiose entre le virus Coxsackie souche neurotrope et le virus rabique fixe. Presse med. 60, 562 (1952).
—:et A. Vaisman:Symbiose entre le virus Coxsackie souche eneephalitogene et le virus de la rage des rues (souche Tanger). Presse med. 60, 562 (1952).
—: Mecanisme de la reeeptivite des souriceaux nouveau-nes et de la resistance des souris adultes a l’egard de l’ultravirus Coxsackie type neurotrope B. Ann. Inst. Pasteur 82, 754 (1952).
—:Mecanisme de la reeeptivite des souriceaux nouveau-nes et de la resistance des:Mecanisme de la reeeptivite des souriceaux nouveau-nes et de la resistance des
—:souris adultes a l’egard de l’ultravirus Coxsackie type neurotrope B. Presse med. 60, 774 (1952).
—:Symbiose des ultra virus neurotropes. Association entre le virus Coxsackie eneephalitogene et le virus de l’herpes. Rev. immun. 16, 117 (1952).
Lindberg, G.: Myalgia epidemica im Kindesalter. Acta paediatr. (Stockh.) 19, 1 (1936).
—:Myalgia epidemica und Poliomyelitis. Klin. Wschr. 1938, 532.
Mac Donald, R. R., B. Hewell and M. L. Cooper: Epidemie myalgia. Amer. J. Dis. Childr. 53, 1425 (1937).
Madsen, Th.: Einfluß der Jahreszeiten auf den Verlauf einiger Infektionskrankheiten auf Grundlage von dänischem Material. Verh. Kongr. inn. Med. 47, 557 (1935).
von Magnus, H.: 2. Internat. Kongr. Innere Med. London 1952.
Isolation of 3 strains of the Coxsackie group of viruses from patients with symptoms of meningeal affection. Ugeskr. Laeg. 111, 1451 (1949).
Manire, G. P., S. E. Sulkin and T. W. Farmer: Complement fixation studies with Coxsackie virus. Proc. Soc. Exper. Biol. a. Med. 73, 341 (1950).
Martin, R., et D. Sureau: Un cas parisien du maladie de Bornholm chez un nourrisson. Arch. frans. Pediatr. 9, 1649 (1952).
Mc Connel, J.: An epidemic of pleurodynia with prominent neurologie symptoms and no demonstrable cause. Amer. J. Med. Sci. 209, 41 (1945).
Measroch, V., J. Dear and G. J. Faerber: Studies in poliomyelitis. The isolation of a Coxsackie-like virus from the feces of apparently healthy Bantu infants. S. Afric. Med. J. 25, 421 (1951).
Meenan, N. P.: New concepts of poliomyelitis. Lancet 755 (1953).
Melnick, J. L.: The poliomyelitis, Encephalomyocarditis and Coxsackie groups of viruses. Baeter. Rev. 14, 233 (1950).
—: Studies on Coxsackie viruses; properties, immunological aspects and distribution in nature Bull. N. Y. Acad. Med. 26, 342 (1950).
—: Epidemie of poliomyelitis charaeterized by dual infections with Coxsackie and poliomyelitis viruses. Federat. Proc. 10, 415 (1951).
—:The Coxsackie group of viruses. Ann. N. Y. Acad. Sci. 56, 585 (1953).
—.and K. Agren: Poliomyelitis and Coxsackie viruses from normal infants in Egypt. Proc. Soc. Exper. Biol. a. Med. 81, 621 (1952).
N. A. Clarke and L. M. Kraft: Immunological reactions of the Coxsackie viruses. III. Cross protection tests in infant mice born of vaccinated mothers. Transfer of immunity through the milk. J. of Exper. Med. 92, 499 (1950).
N. A. Clarke and L. M. Kraft:and G. C. Godman: Pathogenesis of Coxsackie virus infection. Multiplication of virus and evolution of the muscle lesion in mice. J. of Exper. Med. 93, 247 (1951).
—and A. S. Kaplan: Dual antibody response to Coxsackie and poliomyelitis viruses in patients with paralytic poliomyelitis. Proc. Soc. Exper. Biol. a. Med. 74, 812 (1950).
—:Quantitative studies of the virus-host relationship in Chimpanzees after inapparent infection with Coxsackie viruses. The virus carrier state and the development of neutralizing antibodies. J. of Exper. Med. 97, 367 (1953).
E. Zabin, G. Contreras and N. W. Larkum: An epidemic of paralytic poliomyelitis charaeterized bv dual infections with poliomyelitis and Coxsackie viruses. J. of Exper. Med. 94, 471 (1951).
— Contreras and N. W. Larkum:and L. M. Kraft: Differentiation of immunological types among the Coxsackie viruses. Federat. Proc. 9, 585 (1950).
— —and N. Ledinko: Immunological reactions of the Coxsackie viruses. I. Neutralisation test. Technique and applications. J. of Exper. Med. 92, 463 (1950).
— — —:Social serology: antibody levels in normal young population during epidemic of poliomyelitis. Federat. Proc. 9, 387 (1950).
—:Infection of cynomolgus monkeys with the Ohio type of Coxsackie virus. J. of Immun. 64, 101 (1950).
—:Social serology; antibody levels in a normal young population during an epidemic of poliomyelitis. Amer. J. Hyg. 54, 354 (1952).
A. S. Kaplan and M. L. Kraft: Ohio strains of a virus pathogenic for infant mice
(Coxsackie group). Simultaneous occurence with poliomyelitis virus in patients with “summer grippe”. J. of Exper. Med. 91, 185 (1950).
—: Survival of poliomyelitis and Coxsackie viruses following their ingestion by flies. J. of Exper. Med. 96, 255 (1952).
M. Rhian, J. Warren and S. S. Breese: The size of Coxsackie viruses and Lansing poliomyelitis virus as determined by Sedimentation and ultrafiltration. J. of Immun. 67, 151 (1951).
E. W. Shaw and E. C. Curnen: A virus isolated from patients diagnosed as non paralytic poliomyelitis or aseptic meningitis. Proc. Soc. Exper. Biol. a. Med. 71, 344 (1949).
Menut, M. G.: A propos de 5 cas d’affections neurologiques graves de l’enfant dont un Syndrome du Guillain-Barre. Mise en evidence de virus Coxsackie. Presse med. 60, 1066 (1952).
Mollaret, P., J. Reilly. R. Bastin et P. Tournier: La decouverte du virus de la lymphoreticulose benigne d’inoculation. I. Caraeterisation serologique et immunologique. Presse med. 59, 681 (1951).
Morris, J. A.: Neutralizing antibodies against viruses of the Coxsackie group in sera of wild rabbits. Federat. Proc. 10, 416 (1951).
Neutralizing of viruses of the Coxsackie group by sera of wild rabbits. Cornell Veterinarian 42, 56 (1952).
Mulder, J.: Aspects of the influenza problem. Adv. Int. Med. 5, 337 (1952).
Oker-Blom N. and E. Nikkilä: Purification of Coxsackie virus bv use of Montmorillonite. Trans. 10. Scand. Congr. Path. a. Bacter. Acta paediatr. (Stockh.) Suppl. 93, 340 (1952).
N. and P. Pohjanpelto: The occurence of the Coxsackie group of viruses in Finland. Ann. med. exper. et biol. fenn. 31, 166 (1953).
Olitzky, P. K., J. Casals and L. C. Murphy: Diagnostic tests with Albany type 1 and 2 Coxsackie virus. Federat. Proc. 9, 388 (1950).
Ortiz Molina, C.: Tres casos de mialgia epidemica o enfermadad de Bornholm. Rev. clin. espan. 43, 38 (1951).
Oster, E.: Erfahrungen mit der Coxsackie-Komplementbindungsreaktion gegen ein A2- Antigen. Diss. Freiburg 1953.
Pappenheimer, A. M.: Fuchsinophile granules in the tissues of mice infected with the Connecticut 5 strain of Coxsackie virus. J. of Exper. Med. 95, 251 (1952).
J. B. Daniels, F. S. Cheever and T. H. Weller: Lesions caused in suckling mice by eertain viruses isolated from cases of so called non paralvtic poliomyelitis and of pleurodynia. J. of Exper. Med. 92, 169 (1950).
L.J. Kunz and S. Richardson: Excretion of Coxsackie virus (Conn. 5 strain) in the urine of infected mice. Proc. Soc. Exper. Biol. a. Med. 77, 405 (1951).
Pappenheimer, A. M., L. J. Kunz and S. Richardson: Passage of Coxsackie virus (Conn. 5 strain) in adult mice with production of pancreatic disease. J. of Exper. Med. 94, 45 (1951).
Parrot, R. H., S. Ross, F. C. Burke and E.C. Rice: Herpangina. Clinical studies of a specific infectious disease. New England J. Med. 245, 275 (1951).
Patz, J. M.: Bornholm disease, pleurodynia or epidemic myalgia. S. Afric. Med. J. 27, 397 (1953).
Paul, J. R.: Knowledge and trends in poliomyelitis. A Summary. 2. Internat. Poliomyelitis Conference, Copenhagen 1951.
J. T. Riordan and J. L. Melnick: Antibodies to 3 different antigenic types of poliomyelitis virus in sera from North-Alaskan Eskimos. Amer. J. Hyg. 54, 275 (1951).
— and L. M. Kraft: Serological epidemiology: Antibody patterns in North Alaskan
Eskimos, J. of Immun. 66 695 (1951).
J. L. Melnick and J. T. Riordan: Comparative neutralizing antibody patterns to Lansing (type 2) poliomyelitis virus in different population. Amer. J. Hyg. 56, 232 (1952).
Pedro-Pons, A., Y. V. P. Farreras: Mialgia epidemica, meningitis mialgica y virus de Coxsackie. Clinica de cuatro casos de mialgia epidemica observados en Barcelona durante los veranos de 1950 y 1951. Med. clin. (Barcelona) 17, 374 (1951).
Peers, J. H., S. E. Ranson and R. J. Huebner: The pathologic changes produced in chick embryos by yolk sac inoculation of group A Coxsackie virus. J. of Exper. Med. 96, 17(1952).
Petersen, U. K.: Coxsackie-Virus-Infektionen im Kindesalter. Münch, med. Wschr. 1958,743.
Plichet, A.: La maladie de Bornholm et les virus de Coxsackie. Presse med. 58, 857 (1950).
Prenzel, H.: Beobachtungen über epidemisches Auftreten der Bornholmer Krankheit bei Kindern. Mschr. Kinderheilk. 100, 475 (1952).
—: Ultrafiltration and ultraeentrifugation studies of Coxsackie virus. Proc. Soc. Exper. Biol. a. Med. 72, 434 (1949).
—. n of semipurified Coxsackie virus suspension. Annual Rep. Div. Labor. N. Y. State Dep. Health 1950.
— Particle size of Coxsackie virus as estimated by ultrafiltration and ultraeentrifugation. Annual Rep. Div. Labor. N. Y. State Dep. Health 1951.
— Ramirez, C. F.: Zit. nach Curnen, E. C. Immunology and clinical aspects of Coxsackie virus infection. 2. Internat. Poliomyelitis Conference, Copenhagen 1951.
Rasmussen, A. F., F. A. Cline and A. F. Borge: Coxsackie virus infections in northern Wisconsin. Wisconsin Med. J. 52, 129 (1953).
Reed, L. J., and H. Muench: A simple method of estimating 50% endpoint. Amer. J. Hvg. 27, 497 (1938).
Rhodes, A. J., E. M. Clark, D. S. Knowles, F. S. Shimada, W. L. Donohue, P. M. Armstrong, F. H. Wilson, M. J. Mc Lean and N. Silverthorne: Studies on poliomyelitis in Ontario. III. Further observations on association of Coxsackie and poliomyelitis viruses. Canad. J. Publ. Health 41, 183 (1950).
Riordan, J. T., N. Ledinko and J. L. Melnick: Multiplication of poliomyelitis viruses in tissue cultures of monkey testes. II. Direct isolation and typing of strains from human stools and spinal cords in roller tubes. Amer. J. Hyg. 55, 339 (1952).
Robbins, F. C., J. F. Enders, T. H. Weller and G. L. Florentino: Studies on the cultivation of poliomyelitis viruses in tissue culture. V. The direct isolation and Serologie identification of virus strains in tissue culture from patients with non paralvtic and paralytic poliomyelitis. Amer. J. Hyg. 54, 286 (1951).
—: Effect of heat and pn on strains of Coxsackie virus. Proc. Soc. Exper. Biol. a. Med. 75, 580 (1950).
Rohde, W.: Funktionelle Zusammenhänge zwischen Poliomyelitis, Theiler-Virus und Cox- sackie-Infektionen. Wiss. Z. Friedrich Schiller-Univ. Jena 1951/52, 11.
Funktionelle Zusammenhänge zwischen Theiler-Virus-, Poliomyelitis- und Coxsackie- Infektionen. Z. inn. Med. 7, 642 (1952).
Ronse, L.: Virus de Coxsackie, myalgia epidemique ou maladie de Bornholm et nevralgie intercostale. Presse med. 59, 996 (1951).
van Rooyen, C. E., and A. J. Rhodes: Virus diseases of man. New York: Thomas Nelson and Sons 1948.
Roulet, F.: Med. Ges. Basel, Sitzg. v. 25. 10. 1951.
—:Experimenteller Beitrag zur Histopathologie der Coxsackie-Virus-Erkrankungen. Münch, med. Wschr. 1951, 476.
Rowe, P. W.: Propagation of a Coxsackie virus in denervated adult mouse muscles. Science (Lancaster, Pa.) 117, 710 (1953).
de Rudder, B.: Myalgia acuta epidemica (Bornholmer Krankheit und epidemiologische Poliomyelitis). Klin. Wschr. 1987, 585.
—:Grundriß einer Meteorobiologie des Menschen. 3. Auflage, Berlin: Springer-Verlag 1952. Ergebnisse d. Inn. Medizin, N. F. Bd. 5. 2
Rustigian, R., and A. M. Pappenheimer: Myositis in mice, following intramuscular injection of viruses of the mouse encephalomyelitis group and of certain other neurotropie viruses. J. of Exper. Med. 90, 69 (1949).
Sabin, A. B., H. Eichenwald, H. A. Feldman and L. Jacobs: Clinical and Serologie dia-gosis of toxoplasmosis in man. J. Amer. Med. Assoc. 150, 1063 (1952).
Schaeffer, L. F.: Epidemie of Bornholm disease in region of Amsterdam. Nederl. Tijdschr. Geneesk. 95, 2938 (1951).
Schairer, J.: Herstellung von Immunseren und Typendifferenzierungen bei in Deutschland isolierten Coxsackie-Virus-Stämmen. Diss. Freiburg 1952.
Schlack, H.: Herpangina und Stomatitis herpetica. Epidemiologische Beobachtungen in Stuttgart. Dtsch. med. Wschr. 1958, 213.
Schwab, M., R. Allen and S. E. Sulkin: Tropical rat mite (Lvponyssus Bacoti) as an experimental vector of Coxsackie virus. Amer. J. Trop. Med. Hyg. 1, 982 (1952).
Shaw, M.: Growth of viruses in tissue cultures and in embryonated eggs. Annual Rep. Div. Labor. N. Y. State Dep. Health 1951.
—: Cultivation of Coxsackie virus in embryonated eggs and in cliick tissue cultures. Proc. Soc. Exper. Biol. a. Med. 79, 718 (1952).
Shaw, E., J. L. Melnick and E. Cijrnen: Infection of laboratory workers with a virus pathogenic for infant mice. Ann. Int. Med. 33, 32 (1950).
Sickles, G. M., and G. Dalldorf: Serologie differences among strains of Coxsackie group of viruses. Proc. Soc. Exper. Biol. a. Med. 72, 30 (1949).
Sigel, M. M.: Coxsackie viruses and human disease. Adv. Med. Surg. 1952, 372.
Silverthorne, N., M. P. Armstrong, A. M. Gqodfellow, T. E. Roy, R. C. Ritchie, W. L. Donohue, A. J. Rhodes, E. M. Clark, D. S. Knowles, F. T. Shimada and F. H. Wilson: Studies on poliomyelitis in Ontario. IV. Further observations on the spread of poliomyelitis and Coxsackie infections in small communities. Canad. Med. Assoc. J. 64,309 (1951).
C. Anglin and J. B. J. Mc Kendry a. o.: Studies on poliomyelitis in Ontario. V. Further observations on recovery of Coxsackie viruses from cases of clinical poliomyelitis. Canad. Med. Assoc. J. 65, 536 (1951).
Slater, E. A., and J. T. Syverton: The cultivation of Coxsackie virus. Proc. Soc. Exper.
Slater, E. A., and J. T. Syverton:Biol. a. Med. 74, 509 (1950).
Stanley, N. F.: Purification of Australian strains of Coxsackie virus. Austral. J. Exper. Biol. 29, 363 (1951).
—: Attempts to demonstrate interference between Coxsackie and poliomyelitis virus in mice and monkeys. Proc. Soc. Exper. Biol. a. Med. 81, 430 (1952).
—: and D. C. Dorman: A poliomyelitis virus pathogenic for suckling mice and monkeys. Austral. J. Exper. Biol. 31, 1 (1953).
—: Group A Coxsackie viruses isolated from cases of poliomyelitis. Austral. J. Exper. Biol. 31, 8 (1953).
— and J. Ponsford: Antibodies to Coxsackie viruses in pooled human serum. Austral. J. Exper. Biol. 31, 17 (1953).
—: Studies on Australian strains of Coxsackie virus (group A and B). Austral. J. Exper. Biol. 31, 21 (1953).
—: A hitherto undescribed group of Coxsackie viruses associated with an outbreak of encephalitis. Austral. J. Exper. Biol. 31, 31 (1953).
—.: and L. Hayes: Austral. J. Sci. 13, 81 (1950).
—.: and D. C. Dorman: Suckling mouse viruses in New South Wales. Their relationship to the Coxsackie group of viruses. Austral. J. Exper. Biol. 29, 367 (1951).
Stulberg, C. S., R. Schapira and C. R. Eidam: Virus growth in tissue culture fibroblast. II. Coxsackie virus (group B) in cultures of mouse fat tissue. Proe. Soc. Exper. Biol. a. Med. 81, 642 (1951).
Sulkin, S. E., and G. P. Manire: Interference between poliomyelitis virus Lansing and Coxsackie virus. Texas Rep. Biol. a. Med. 8, 368 (1950).
—, and G. P. Manire:and T.W.Farmer: Gross neutralization tests with Coxsackie viruses. Proc. Soc. Exper. Biol. a. Med. 73, 340 (1950).
M. Schwab and H. C. Wallis: Isolation of Coxsackie viruses. Litter differences among suckling mice. Proc. Soc. Exper. Biol. a. Med. 77, 354 (1951).
— and H. C. Wallis:and H. C. Wallis: Effect of ether on certain Coxsackie viruses. Proc. Soc. Exper. Biol. a. Med. 81, 151 (1951).
— and H. C. Wallis:and P. Donaldson: Differentiation of Coxsackie viruses by altering susceptibility of mice with Cortisone. J. Inf. Dis. 91, 290 (1952).
Swain, R. H. A., and R. G. Mitchell: The isolation of Coxsackie virus from two cases of Bornholm disease. Brit. Med. J. Nr. 4824, 1354 (1953).
Sylvester, D. G. H.: Epidemic of benign dry pleurisy. Brit. Med. J. Nr. 4680, 653 (1950).
Teusch, W.: Herpangina Symptom oder Krankheit ? Med. Mschr. 7, 180 (1953).
Thelin, F., et J. Werth: La myalgie epidemique. (Maladie de Bornholm). Rev. med. Suisse rom. 71, 44 (1951).
Thordarson, O. T.: 2. Internat. Kongr. Inn. Med., London 1952.
Top, F. H.: Die Coxsackie-Viren mit besonderer Berücksichtigung ihrer Beziehungen zum Poliomyelitis-Virus. Dtsch. med. J. 2, 513 (1951).
The Coxsackie viruses; with a consideration of their relationship to the virus of poliomyelitis. A review. Z. Hyg. 134, 183 (1952).
Traub, E: In Gildemeister-Hagen, Handbuch der Viruskrankheiten. 1939.
Verlinde, J. D.: A comparative study on muscular involvement in experimental poliomyelitis indueed by various strains of virus and the effect of hyaluronidase on the intramuscular inoculation. Arch. Virusforsch. (Wien) 4, 546 (1952).
— H. A. E. van Tongeren: Poliomyelitis en infectie met Coxsackie-virus. Nederl. Tijdschr. Geneesk. 96, 2404 (1952).
—:A mixed epidemic of poliomyelitis and Bornholm disease (pleurodynia). Leeuwenhoek J. Microbiol. a. Serol. 18, 239 (1952).
Vivell, O.: Experimentelle Untersuchungen zur Virusinterferenz. Tagg. südwestdtseh. Kinderärzte, Tübingen 1950.
—: Experimentelle Untersuchungen zur Selbstinterferenz des MM-Virus. Z. Kinderheilk. 70, 113 (1951).
—: Über Interferenzerscheinungen bei Infektionskrankheiten. Erg. inn. Med. N. F. 2, 680 (1951).
—: Vergleichende Untersuchungen zwischen dem Sabin-FELDMANSchen Farbtest auf Toxoplasmose und dem Toxoplasminhauttest. Z. Kinderheilk. 70, 271 (1951).
—: Über die Bedeutung des Antikörpernachweises für die Diagnose der konnatalen Toxoplasmose. Tagg. südwestdtseh. Kinderärzte, Stuttgart 1952.
—: Poliomvelitis und Coxsackie-Virus-Infektion. Ärztl. Wschr. 1952, 502.
—: Schlußwort zu Thalhammer. Z. Kinderheilk. 72, 70 (1952).
—: Die Coxsackie-Viren als Krankheitserreger. Vortrag vor der Ges. Hygiene u. Mikrobiologie, der kinderärztl. Ges. u. d. Ges. path. Anat., Wien, 27. 4. 1953.
—: Die Viren der Coxsackie-Gruppe. Eine Übersicht unter besonderer Berücksichtigung eigener virologisch-serologischer Studien. Habilitationsschrift Freiburg 1953.
—: Ergebnisse serologischer Studien bei Coxsackie-Viren. (In Vorbereitung.)
—: Vergleichende Antikörperstudien bei Virusinfektionen. (In Vorbereitung.)
—: u. H. W. Buhn: Toxoplasmose und Gravidität. Ärztl. Forsch. 7, 326 (1953).
—: u. R. Gädeke: Die Viren der Coxsackie-Gruppe. Erg. Hyg. 27, 512 (1952).
—: D. Roland u. K. Sievers: Klinische, virologische und pathologisch-anatomische Beobachtungen bei Coxsackie-Virus-Infektionen. Dtsch. med. Wschr. 1952, 973.
—: A. Gerstner u. K. Yolageldili: Untersuchungen über die Hämagglutination von Viren der Parapoliomyelitisgruppe. III. Mitteilung. Zur Frage der Spezifität des Hämagglu- tinationshemmungstestes sowie weitere Ergebnisse serologischer Studien. Z. Immun, forsch. 109, 527 (1952).
—: u. E. Grämlich: Zur Klinik und Serologie der Mumpsmeningoeneephalitis. Ms ehr. Kinderheilk. 101, 341 (1953).
—:u. R. Marquart: Die praktische Bedeutung der serologischen Mumpsdiagnose. Dtsch. med. Wschr. (Im Druck.)
—: u. R. Mauer: Untersuchungen über die Hämagglutination von Viren der Parapoliomyelitisgruppe (Encepha] ornyokarditisgruppe). I. Mitteilung. Zur Charakteristik des Hämagglutüiationsphänomens. Z. Immun.forsch. 109, 246 (1952).
—: u. K. Oster: Über die diagnostische und klinische Bedeutung der Coxsaekie-Komplement- bindungsreaktion. Ärztl. Wschr. 1953, 58.
—: u. J. Schairer: Typenbestimmungsversuche bei in Deutsehland isoHerten Coxsackievirus-Stämmen. Arch. Virusforsch. (Wien) 5, 84 (1953).
—: E. Schmitt u. A. Gerstner: Untersuchungen über die Hämagglutination von Viren der Parapoliomyelitisgruppe (Encephalomyokarditisgruppe). II. Mitteilung. Über einen neuen Hämagglutinationshemmungstest nach der Methode von Herst. Ergebnisse serologischer Untersuchungen. Z. Immmi.forseh. 109, 274 (1952).
Vögtli, C.: Über die Wiggenthaler- Ol tener Epidemie. Korresp.bL Schweiz. Ärzte 10, 7 (1880).
Wallgren, A.: Die Ätiologie der Eneephalomeningitis bei Kindern, besonders des Syndroms der akuten abakteriellen (aseptischen) Meningitis. Acta paediatr. (Stockh.) 40, 541 (1951).
Ward, R.: Poliomyelitis and Coxsackie viruses from Egvptian flies. Federat. Proc. 11, 486 (1952).
Warin, J. F.: Oxford epidemic of Bornholm disease 1951. Brit. Med. J. Nr. 4824, 1345 (1953).
Webb, C. H., S.G. Wolfe and B. F. Howitt: Three day fever. Acute febrile disease of childhood. (Further observations) with virus laboratory studies and isolation of Coxsackie virus. Amer. J. Dis. Childr. 80, 245 (1950).
Weber, E.: Grundriß der biologischen Statistik. Jena: Fischer 1948.
Weller, T. H., J. F. Enders, M. Bttckingham and J. J. Pinn: The etiology of epidemic pleurodynia; a study of two viruses isolated from a typical outbreak. J. of Immun. 65, 337 (1950).
A. M. Pappenheimer, M. Bttckingham and J. J. Finn: Isolation of a filtrable agent from throat washings collected during an outbreak of epidemic pleurodynia. Soc. Pediatr. Res. S. May 1950, French Lick.
A. M. Pappenheimer, M. Bttckingham and J. J. Finn: F. C. Robbins and M. B. Stoddard: Federat. Proc. 11, 486 (1952); zit. nach J. L. Melnick, The Coxsackie group of viruses. Ann. N. Y. Acad. Sci. 56, 585 (1953).
Windoreer, A.: Die Ausbreitung der Poliomyelitis in Deutschland Scit Ende des Zweiten Weltkrieges. Dtsch. med. Wschr. 1953, 975.
—: Briefliche Mitteilung.
—: Die Bornholmer Krankheit. Kinderärztl. Prax. 11, 256 (1953).
—.: u. M. Born: Über die meningitische Form der Bornholmer Krankheit. „Meningitis myalgica”. Dtsch. med. Wschr, 1952, 1012.
Wirth, J.: La deviation du eomplement avec l’antigene de Coxsackie (A 6) etudiee parallelement a l’epidemie saisonnaire de poliomyelite. Praxis (Bern) 41, 457 (1952).
—: Le laboratoire et les maladies a virus. Med. et hyg., Geneve 9, 257 (1951).
—, et F. Thelin: Isolement d’un agent apparente au virus de Coxsackie: Application au diagnostic clinique au moyen de la reaetion de fixation du eomplement. Praxis (Bern) 39, 949 (1950)
—: Les virus de Coxsackie; rapports avec les nevraxites et la poliomyelite. Clinique et laboratoire. Soc. Med. de Geneve 6. 11. 1951.
Zahorsky, J.: Herpetic sore throat. South Med. J. 13, 871 (1920).
—: Herpangina. (Specific infeetious disease.) Arch. of Pediatr. 41, 181 (1924).
Zweymüller, E.: Coxsackie-Virus-Befund bei einem Kind mit Dermatomyositis. Wien. klin. Wschr. 1952, 479.
—: Schwere Haut-Muskelerkrankung unter dem klinischen Erscheinungsbild einer Dermatomyositis mit Coxsackie-Virusbefund. Dtsch. med. Wschr. 1953, 190.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1954 Springer-Verlag OHG.
About this paper
Cite this paper
Keller, W., Vivell, O. (1954). Poliomyelitis-ähnliche Krankheitsbilder und ihre Erreger beim Menschen. In: Heilmeyer, L., Schittenhelm, A., Schoen, R., Glanzmann, E., De Rudder, B. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94621-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-94621-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94622-6
Online ISBN: 978-3-642-94621-9
eBook Packages: Springer Book Archive